Stock round-up (3) SanBio, Note SanBio announced the initiation of a clinical trial for its regenerative medicine. The company aims to develop treatments for spinal cord injuries. Note, a tech company, released a new version of its digital notebook app with enhanced features. The update includes improved handwriting recognition and cloud synchronization.

NIKKEI QUICK · 3d ago

Please log in to view news